Acalabrutinib(ACP-196) is a selective second-generation Brutons tyrosine kinase (BTK) inhibitor, which prevents the activation of the B-cell antigen receptor (BCR) signaling pathway.BMX, and TEC, respectively) and no activity against EGFR.
Molecular Weight:
465.51
Purity:
99.21%
CAS Number:
[1420477-60-6]
Formula:
C26H23N7O2
Target:
BTK
* VAT and and shipping costs not included. Errors and price changes excepted